Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73604427" target="_blank" >RIV/61989592:15110/20:73604427 - isvavai.cz</a>
Result on the web
<a href="https://www.researchgate.net/publication/339881267_Potential_use_of_radiolabelled_neurotensin_in_PET_imaging_and_therapy_of_patients_with_pancreatic_cancer" target="_blank" >https://www.researchgate.net/publication/339881267_Potential_use_of_radiolabelled_neurotensin_in_PET_imaging_and_therapy_of_patients_with_pancreatic_cancer</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/MNM.0000000000001172" target="_blank" >10.1097/MNM.0000000000001172</a>
Alternative languages
Result language
angličtina
Original language name
Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer
Original language description
Pancreatic cancer is the fourth leading cause of cancer-related death in both men and women. Neurotensin receptors are overexpressed in different malignancies, above all pancreatic cancer. On the other hand, neurotensin receptor expression in inflammation is quite low. This fact can probably solve the most important problem of F-FDG PET imaging - distinguishing malignant and inflammatory processes. The first therapeutic injection of radiolabelled neurotensin in human with pancreatic cancer has been successfully performed. Animal experiments are also very close to the first in human injection of radiolabelled neurotensin for diagnostic purposes. The purpose of this article is to provide an overview of radiolabelled neurotensin analogues that can be used in imaging and therapy in patients with pancreatic ductal adenocarcinoma.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30224 - Radiology, nuclear medicine and medical imaging
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
NUCLEAR MEDICINE COMMUNICATIONS
ISSN
0143-3636
e-ISSN
—
Volume of the periodical
41
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
5
Pages from-to
"411 "- 415
UT code for WoS article
000531338900001
EID of the result in the Scopus database
2-s2.0-85083041368